Portable electronic device having mobile communication capability

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Nintendo Co., Ltd. patent solves the following problem:

This creation generally relates to a portable game machine and, particularly, a portable game machine that selectively configurable for one or more of the various operations such as wireless communication, global positioning, image capture and its activities.

Our analysis of this patent is as follows:

Nintendo Co., Ltd.’s patent US 9457266 B2 deals with Portable electronic device having mobile communication capability.
An example portable electronic device includes a display; user controls; a camera to take pictures; wireless communication circuitry for mobile communication; memory; and a processing system for the control of the portable electronic device. The processing system controls the portable electronic device that can contain an outgoing message and can see a future messages. An image captured on camera and shown in the display is stored in memory in response to an input of user controls. The wireless communication circuitry, under control of the processing system, pass the outgoing message and receive future messages. The processing system controls the display simultaneously present in the received message and a linear arrangement of the image.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

System, method, and computer program product for input/output buffer modeling

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Cadence Design Systems, Inc. patent solves the following problem:

Our analysis of this patent is as follows:

Cadence Design Systems, Inc.’s patent US 9460250 B1 deals with System, method, and computer program product for input/output buffer modeling.
The present disclosure relates to a computer-implemented method for transient simulation of an input / output buffer models. methods may include the creation of an input / output buffer data file associated with a first model of an electrical circuit. method may also include determining at least one of a node voltage and a current branches associated with the electrical circuit in use, at least in part, a way latency insertion, the method may further include performing one or more simulations at a second model of an electrical circuit, one or more superstitious use, at least in part, the input / output buffer data file and the latency insertion method.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method and apparatus for managing a gaming application

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The At&T; Intellectual Property I, L.P. patent solves the following problem:

Gaming consoles now support multiplayer games that can be played from a gaming console, or between the Gaming consoles are located in remote areas when players subscribe to online services to play. Smart phone also adapted to download the games that users can play each of their Smart phone or among the users of its smart phone over a wireless communication system.

Our analysis of this patent is as follows:

At&T; Intellectual Property I, L.P.’s patent US 9457271 B2 deals with Method and apparatus for managing a gaming application.
A picture of the present disclosure include, for example, a method for receiving from a first device to a request to start a video game with a second device, determine the one of the first device, recognition of a difference between the first computing resources for the first device and the second computing resources on second thoughts, teaching first device, the second device, or both to adjust a resource configuration to reduce a portion of the difference between the first computing resources and the second computing resources, and coordination of a first exchange of control information given to the first device and the second control information given the second device to a multiplayer video game sessions between the first device and the second device. Other embodiments are disclosed.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Auspex Pharmaceuticals, Inc. patent solves the following problem:

The present invention is directed to the inhibitor of the uptake of monoamine neurotransmitters and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the medical use of such compounds for the treatment and / or management of psychotropic disorders , anxiety disorder, generalized anxiety disorder, depression, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, hot flashes, senile dementia, migraine, hepatopulmonary syndrome, chronic pain, nociceptive pain, neuropathic pain, pain diabetic retinopathy, bipolar depression, obstructive sleep apnea, psychiatric disorder, premenstrual dysphoric disorder, social excessive fear, social anxiety disorder, urinary incontinence, anorexia, bulimia nervosa, obesity, ischemia, head injury, calcium overload in cells brain, drug dependence, and / or premature release.

Our analysis of this patent is as follows:

Auspex Pharmaceuticals, Inc.’s patent US 9458082 B2 deals with Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity.
Chemical syntheses and medical use of novel inhibitor of monoamine uptake of neurotransmitters and pharmaceutically acceptable salts and prodrugs thereof, for the treatment and / or administration of psychotropic disorder, anxiety disorder, generalized anxiety disorder, depression, post-traumatic stress disorder, Obsessive- compulsive disorder, panic disorder, hot flashes, senile dementia, migraine, hepatopulmonary syndrome, chronic pain, nociceptive pain, neuropathic pain, painful diabetic retinopathy, bipolar depression, obstructive sleep apnea, psychiatric disorder, premenstrual dysphoric disorder, social excessive fear, social anxiety disorder, urinary incontinence, anorexia, bulimia nervosa, obesity, ischemia, head injury, calcium overload in brain cells, drug dependence, and / or premature release described.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Initial camera mode management system

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Gopro, Inc. patent solves the following problem:

It disclosure relates to a system to handle the camera, and more specifically, the detection devices in a system camera, the passing of credentials between the cameras and other devices, and to manage camera operation way.

Our analysis of this patent is as follows:

Gopro, Inc.’s patent US 9462186 B2 deals with Initial camera mode management system.
A camera detects devices, like other cameras, smart devices, and access points, the camera to speak. camera can be different between operating as a wireless station and a wireless access point. camera can connect to and receive credentials from one device to another device that is not connected. In one embodiment, the camera is configured to operate as a wireless access point, and configured to receive credentials from a smart device operates as a wireless station. camera can then transfer the credentials of more cameras, each configured to operate as a wireless station. The camera and additional camera to connect to a Smart device directly or indirectly (eg, through an access point), and the Smart devices can change the way camera to camera. The first step in the camera to be preserved and restored by the Smart device upon disconnection.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Internal magnetic filter for hydraulic systems

File for Quick & Easy Patent Protection with PowerPatent.

The BBB Industries LLC patent solves the following problem:

Disclosure This related to the field of hydraulic systems filtration, in particular, the filtering devices and machinery used to remove debris from the automotive power steering fluid circulating through a power steering system .

Our analysis of this patent is as follows:

BBB Industries LLC’s patent US 9457300 B2 deals with Internal magnetic filter for hydraulic systems.
A simple inlet filter elements for use primarily in the power steering column that contains a filter mesh, a magnet attached to the mesh filter and a button cap. filter to install a dock or canal through which fluid flows and directing made on the button cap element.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Highly concentrated aqueous protein solution with reduced viscosity

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Adocia patent solves the following problem:

Our analysis of this patent is as follows:

Adocia’s patent US 9457089 B2 deals with Highly concentrated aqueous protein solution with reduced viscosity.
In an aqueous solution, a composition includes at least one protein, including at least one antibody fragments, and at least one water-soluble viscosity-reducing agent selected from the group consisting of cytidine, 2-deoxycytidine, uridine, 2-deoxyuridine, thymidine and ribothymidine, alone or as a mixture. proteins include at least one antibody fragment in a concentration greater than or equal to 50 mg / ml.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Container for the generation of therapeutic microfoam

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Btg International Limited patent solves the following problem:

Sclerosis of varicose veins is based on vein injection of liquid sclerosant substances which, by inter alia causing a localized inflammatory reaction, favor the elimination of these abnormal veins. Until recently, sclerotherapy was a technique selected in cases of small and medium caliber varicose veins, those with diameters equal to or greater than 7 mm being treated by surgery. Sclerotherapy and operation nagkakomplimento one another, but to treat with sclerotherapy continues to apply to large varicose veins. In these large varicose veins, if a sclerosing liquid is injected, the amount of liquid sclerosant necessary to fill the entire length of the varicose vein exceeded safe limits dose to normal sclerosant concentration, and may be effective concentration needed to limit the dose to safe levels. Furthermore, its concentration in the vein, the uniform distribution of blood, and the period for which it is in contact with the internal walls of the vessel treated were not known.

Our analysis of this patent is as follows:

Btg International Limited’s patent US 9457160 B2 deals with Container for the generation of therapeutic microfoam.
Device containing sclerosant liquid for use in the treatment of blood vessels with an aerosol valve housing containing a gas entry port. The aerosol valve housing sitting in a canister containing an expandable inner vessel which sclerosant fluid available. The expandable container affixed to the outer opening of the canister or aerosol valve housing on the gas valve port-entry to gas taken from within the expandable container can mix with sclerosant liquid to make a micro bubbles, so that the introduction of pressurized gas through the aerosol valve causing expandable container to inflate to accommodate the pressurized gas.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Acoustophoretic device with piezoelectric transducer array

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Flodesign Sonics, Inc. patent solves the following problem:

The ability to separate a particle / fluid mixture into its separate components is desirable in many applications. Acoustophoresis is the separation of particles using high intensity sound waves, and without the use of membranes or physical size exclusion filtering. It is known that the high intensity standing sound waves can exert forces on particles in a fluid when there is a differential in both density and / or compressibility, known locally as the acoustic differences matter. The profile of the pressure of a standing wave comprising the areas of local minimum pressure the magnitude of the nodes and the local maxima of his anti-nodes. Depending on the density and compressibility of the particles, they are trapped in the nodes or anti-nodes of the standing wave. The higher the frequency the standing wave, the smaller the particles to be trapped by the pressure of the standing wave.

Our analysis of this patent is as follows:

Flodesign Sonics, Inc.’s patent US 9457302 B2 deals with Acoustophoretic device with piezoelectric transducer array.
An apparatus for separating particles from a fluid stream includes a course to the extent that there is at least one inlet and at least one outlet. At least one ultrasonic transducer located in a wall of the flow chamber. transducer includes a piezoelectric war with at least two piezoelectric elements. The piezoelectric forest includes a piezoelectric material to create a multi-dimensional acoustic standing wave in the flow chamber. A reflector located on the wall on the other side of the flow chamber from at least one ultrasonic transducer.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nucleic acid molecules encoding antibodies which bind CCR4 and uses thereof

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Cancer Research Technology Limited patent solves the following problem:

With more than 800 members, G-protein-coupled receptor (GPCRs) represent the largest family of cell surface molecules involved in signal transmission, accounting for 2% of the total gene encoded human genome. The members of the GPCR share a common membrane Topology: an extracellular N-terminus, an intracellular C-terminus and seven transmembrane (TM) helices connected by three intracellular loops and three extracellular loops. On the basis of their shared topological structure, GPCRs are also referred to as seven transmembrane (7tm) receptor. These receptors control key physiological functions, including neurotransmission, hormone and enzyme release from endocrine and exocrine glands, immune responses, cardiac- and smooth-muscle and blood pressure regulation. Their dysfunction contributes to some of the most widespread human diseases. Emerging experimental and clinical data showed that GPCRs have an important role in cancer growth and metastasis. Therefore, the possibility exists that some GPCRs could be target for anti-cancer drugs.

Our analysis of this patent is as follows:

Cancer Research Technology Limited’s patent US 9458238 B2 deals with Nucleic acid molecules encoding antibodies which bind CCR4 and uses thereof.
The present invention provides antibodies that bind to an epitope in the extracellular domain of human CC chemokine receptor 4 (CCR4) and that is capable of inhibiting the binding of macrophage-derived chemokine (MDC) and / or thymus and activation regulated chemokine (TARC) CCR4. Also provides inter alia immunoconjugates and compositions comprising these antibodies and methods and uses involving the same antibody, particularly in the medical and diagnostic fields.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.